StockData
iBio, Inc. logo

iBio, Inc. (IBIO) stock

IBIONasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/30
$0.85+0.10 (+13.37%)

Close on Nov 18, 2026Market cap $54.54MP/E –Yield –

iBio revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

iBio's revenue for the twelve months ending Sep 30, 2026 was $1.08M, up 115.0% year over year. For fiscal 2026 it was $100.00K, down 75.0% from the year before. Over ten years it grew -20.1% a year on average. The highest annual figure on record is $2.37M in fiscal 2021.

Annual revenue

PeriodPeriod endValueChange
FY2026Jun 30, 2026$100.00K-75.0%
FY2025Jun 30, 2025$400.00K+77.8%
FY2024Jun 30, 2024$225.00K–
FY2023Jun 30, 2023$0-100.0%
FY2022Jun 30, 2022$1.88M-20.5%
FY2021Jun 30, 2021$2.37M+44.7%
FY2020Jun 30, 2020$1.64M-18.8%
FY2019Jun 30, 2019$2.02M+354.5%
FY2018Jun 30, 2018$444.00K+12.7%
FY2017Jun 30, 2017$394.00K-58.4%
FY2016Jun 30, 2016$948.00K-48.8%
FY2015Jun 30, 2015$1.85M+802.9%
FY2014Jun 30, 2014$205.00K-79.6%
FY2013Jun 30, 2013$1.01M-21.1%
FY2012Jun 30, 2012$1.28M+145.5%
FY2011Jun 30, 2011$520.08K–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Sep 30, 2026$1.08M+975.0%
Q4 FY2026CQ2 2026Jun 30, 2026$0-100.0%
Q3 FY2026CQ1 2026Mar 31, 2026$0–
Q2 FY2026CQ4 2025Dec 31, 2025$0-100.0%
Q1 FY2026CQ3 2025Sep 30, 2025$100.00K–
Q4 FY2025CQ2 2025Jun 30, 2025$200.00K+14.3%
Q3 FY2025CQ1 2025Mar 31, 2025$0–
Q2 FY2025CQ4 2024Dec 31, 2024$200.00K–
Q1 FY2025CQ3 2024Sep 30, 2024$0-100.0%
Q4 FY2024CQ2 2024Jun 30, 2024$175.00K–
Q3 FY2024CQ1 2024Mar 31, 2024$0–
Q2 FY2024CQ4 2023Dec 31, 2023$0–
Q1 FY2024CQ3 2023Sep 30, 2023$50.00K–
Q4 FY2023CQ2 2023Jun 30, 2023$0–
Q3 FY2023CQ1 2023Mar 31, 2023$0-100.0%
Q2 FY2023CQ4 2022Dec 31, 2022$0-100.0%
Q1 FY2023CQ3 2022Sep 30, 2022$0-100.0%
Q4 FY2022CQ2 2022Jun 30, 2022$0-100.0%
Q3 FY2022CQ1 2022Mar 31, 2022$1.80M+339.0%
Q4 FY2021CQ2 2021Jun 30, 2021$491.00K-56.2%
Q3 FY2021CQ1 2021Mar 31, 2021$765.00K+696.9%
Q2 FY2021CQ4 2020Dec 31, 2020$705.00K+124.5%
Q1 FY2021CQ3 2020Sep 30, 2020$410.00K+279.6%
Q4 FY2020CQ2 2020Jun 30, 2020$1.12M+40.9%
Q3 FY2020CQ1 2020Mar 31, 2020$96.00K-81.8%
Q2 FY2020CQ4 2019Dec 31, 2019$314.00K-51.8%
Q1 FY2020CQ3 2019Sep 30, 2019$108.00K+140.0%
Q4 FY2019CQ2 2019Jun 30, 2019$795.00K+773.6%
Q3 FY2019CQ1 2019Mar 31, 2019$527.00K+575.6%
Q2 FY2019CQ4 2018Dec 31, 2018$651.00K+325.5%
Q1 FY2019CQ3 2018Sep 30, 2018$45.00K-63.1%
Q4 FY2018CQ2 2018Jun 30, 2018$91.00K-38.1%
Q3 FY2018CQ1 2018Mar 31, 2018$78.00K+110.8%
Q2 FY2018CQ4 2017Dec 31, 2017$153.00K+104.0%
Q1 FY2018CQ3 2017Sep 30, 2017$122.00K-9.6%
Q4 FY2017CQ2 2017Jun 30, 2017$147.00K–
Q3 FY2017CQ1 2017Mar 31, 2017$37.00K–
Q2 FY2017CQ4 2016Dec 31, 2016$75.00K–
Q1 FY2017CQ3 2016Sep 30, 2016$135.00K–

More iBio figures

See a number that looks wrong?